Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001330213 | SCV001521831 | uncertain significance | Intellectual developmental disorder with neuropsychiatric features | 2019-02-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Fulgent Genetics, |
RCV001330213 | SCV002775714 | uncertain significance | Intellectual developmental disorder with neuropsychiatric features | 2021-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035690 | SCV004951936 | uncertain significance | not specified | 2023-02-09 | criteria provided, single submitter | clinical testing | The c.1582G>A (p.V528I) alteration is located in exon 5 (coding exon 5) of the SLC45A1 gene. This alteration results from a G to A substitution at nucleotide position 1582, causing the valine (V) at amino acid position 528 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |